Investor Presentaiton

Expand from Blood Center Business to Therapeutic Apheresis and Cell Therapy Differentiated products Solution to new needs Lever OJP M&A and R&D External techs and B2B Hematopoietic stem cell transplant Regenerative medicine systems Therakos UV treatment HEST Chronic GVHD* side-effect solution *One of complications caused by organ transplant Make the de facto standard of production technology in regenerative medicine and cell therapy TERUMO O Terumo Corporation 2018/11/8 11/13

View entire presentation